An SEC filing shows partner CoreWeave has sold its entire stake in Applied Digital. The news is sending APLD's stock price lower Friday amid very high short interest. 3 Summer "Power Patterns" Are About to Trigger ( One With 90% Win Rate ) - Get The Details Now

Stock market information ...

US Foods Hldg USFD has outperformed the market over the past 5 years by 15.72% on an annualized basis producing an average annual return of 29.67%. Currently, US Foods Hldg has a market capitalization of $17.74 billion.

Analysts told Decrypt that the alpha crypto's risk-asset behavior contrasts with gold's safe-haven rally, splitting the reaction.

Safety and quality control issues surrounding Boeing Co. BA aircraft are back in the spotlight after a fatal crash involving a Boeing 787 Dreamliner, operated by Air India, claimed 241 lives in the Indian city of Ahmedabad on Thursday. There were 242 people onboard, including the crew.

Investors with a lot of money to spend have taken a bullish stance on RH RH. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know.

The idea of Bitcoin as a reserve currency has gained traction in countries facing inflation, sanctions, or banking instability. Armstrong noted that stablecoins solve payments, while Bitcoin is increasingly seen as the digital age's store of value.

NEW YORK, June 13, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Fortrea Holdings, Inc. FTRE between July 3, 2023 and February 28, 2025, both dates inclusive ( the "Class Period" ) , of the important August 1, 2025 lead ...

Medtronic plc MDT announced on May 21 its plans to separate its Diabetes business into a separate, publicly traded company. The separation will occur via a two step transaction - an initial minority IPO carve-out followed by a split-off of the remaining stake.

NEW YORK, June 13, 2025 ( GLOBE NEWSWIRE ) -- Tiziana Life Sciences, Ltd. ( Nasdaq: TLSA ) ( "Tiziana" or the "Company" ) , a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal ...